| abstract |
The subject of the application is a 2- (2,5-dioxopyrrolidin-1-yl) propanamide derivative with the R configuration of the stereogenic center selected from: (2R) -N-benzyl-2- (2,5-dioxopyrrolidin-1-yl) propanamide of the formula 1 and (2R) -2- (2,5-dioxopyrrolidin-1-yl) -N- (2-fluorobenzyl) propanamide of formula 2. The application also includes the use of the above-mentioned a compound in the treatment or prevention of epilepsy, epilepsy with associated depressive and anxiety disorders, depression, anxiety, neurological pain, inflammatory pain or a neurodegenerative disease. |